DELAY - 761 ads

Friday, August 01, 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Thursday, July 31, 2025

Quantity : 20mg*10via - Price : USD 300

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Thursday, July 31, 2025

Quantity : 15mg*10via - Price : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Thursday, July 31, 2025

Quantity : 10mg*10via - Price : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Thursday, July 31, 2025

Quantity : 5mg*10vial - Price : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday, July 29, 2025

Quantity : 60mg*10via - Price : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday, July 29, 2025

Quantity : 50mg*10via - Price : USD 550

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday, July 29, 2025

Quantity : 40mg*10via - Price : USD 450

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday, July 29, 2025

Quantity : 30mg*10via - Price : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday, July 29, 2025

Quantity : 20mg*10via - Price : USD 300

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday, July 29, 2025

Quantity : 15mg*10via - Price : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday, July 29, 2025

Quantity : 10mg*10via - Price : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday, July 29, 2025

Quantity : 5mg*10vial - Price : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Saturday, July 26, 2025

Quantity : 5mg*10vial - Price : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday, July 25, 2025

Quantity : 60mg*10via - Price : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday, July 25, 2025

Quantity : 50mg*10via - Price : USD 550

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday, July 25, 2025

Quantity : 40mg*10via - Price : USD 450

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday, July 25, 2025

Quantity : 30mg*10via - Price : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday, July 25, 2025

Quantity : 20mg*10via - Price : USD 300

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday, July 25, 2025

Quantity : 15mg*10via - Price : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday, July 25, 2025

Quantity : 10mg*10via - Price : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday, July 25, 2025

Quantity : 5mg*10vial - Price : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday, July 09, 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday, July 04, 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday, June 25, 2025

Liyond's F6 Auxiliary Switch, a prime example of what is auxiliary switch, is primarily used for control of opening, closing, interlocking, and signals in operating mechanisms of various high-voltage circuit breakers and high-voltage isolating switches. The auxiliary circuit switch...

Wednesday, June 25, 2025

Liyond's FK10 series auxiliary contact, functioning as an essential auxiliary switch in circuit breaker control circuits, is primarily used for control conversion circuits in auxiliary electric circuits of AC/DC vacuum contactors. It also functions as an auxiliary contact in other...

Wednesday, June 25, 2025

Liyond's F10 Auxiliary Switch is a vital auxiliary switch in circuit breaker, controlling circuits for high-voltage and isolating switches. Its working principle involves a movable contact rotated by a square shaft (60°, 90°, or 120°) for seamless contact or separation, enabling reliable...

Wednesday, June 25, 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday, June 06, 2025

Price : 50$

NADcells NAD⁺ (nicotinamide adenine dinucleotide) is an important coenzyme present in human cells. It plays a core role in cellular energy production, DNA repair, antioxidant defense and anti-aging. As we age, NAD⁺ levels in the body decrease, which can lead to fatigue, slower metabolism...

Thursday, May 08, 2025

There are many benefits to getting older and wiser, but most of us would agree that it would be nice to turn back the clock on our faces to reduce the visible signs of age, sun damage, or embarrassing warts or moles. Or maybe you have recently had a baby and the stretch marks are...